🇺🇸 FDA
Patent

US 8163881

Immunoglobulin molecules with improved characteristics

granted A61KA61K2039/505A61K47/6803

Quick answer

US patent 8163881 (Immunoglobulin molecules with improved characteristics) held by The Board of Regents of the University of Texas System expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61K47/6803, A61K49/0058, A61K51/1075